{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:22:44Z","timestamp":1785532964086,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>This review critically appraises the 2024 Liver Imaging Reporting and Data System (LI-RADS) Treatment Response Algorithm (TRA), which introduces separate non-radiation and radiation treatment response pathways and optional MRI ancillary features, and provides evidence-based guidance for clinical implementation. The updated framework addresses key limitations of the prior algorithm, including moderate sensitivity for residual viable hepatocellular carcinoma (HCC), ambiguity of the Equivocal category, and overcalling after radiation therapy. The 2024 update simplifies viability assessment by emphasizing mass-like enhancement as the dominant sign of residual tumor, introduces a radiation-specific Nonprogressing category based on interval behavior, and allows cautious use of diffusion-weighted and T2-weighted MRI ancillary features in selected non-radiation cases. These changes are expected to improve earlier detection of clinically relevant residual disease while reducing false-positive viable calls after radiation-based therapies. Successful implementation requires high-quality imaging, treatment-specific reporting, multidisciplinary review, and awareness of current scope limitations, particularly in patients receiving systemic or combined therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Critical relevance statement<\/jats:title>\n                    <jats:p>The LI-RADS v2024 update critically assesses prior flaws by establishing separate non-radiation and radiation treatment response algorithms, directly advancing clinical practice by reducing false-positive viable calls and standardizing surveillance after complex therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Update resolves inconsistency by establishing separate algorithms for non-radiation and radiation therapies, significantly reducing false-positive \u201cViable\u201d calls after radiation treatment.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Viability criteria are streamlined to rely on mass-like enhancement and optionally include DWI\/T2 ancillary features, improving sensitivity for early recurrence detection. These ancillary features require cautious interpretation to minimize false-positive viable calls.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Viable lesions prompt intervention, while Nonprogressing lesions warrant close, standardized 3-month surveillance to confirm definitive local control. Typically, short-interval follow-up is performed at ~3 months, but the optimal stability threshold remains undefined.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-026-02290-9","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:09:10Z","timestamp":1777302550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The 2024 LI-RADS treatment response update: practical reporting after non-radiation and radiation locoregional therapies for hepatocellular carcinoma"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5466-3879","authenticated-orcid":false,"given":"Jernej","family":"Lu\u010dev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"2290_CR1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222801","volume":"307","author":"V Chernyak","year":"2023","unstructured":"Chernyak V, Fowler KJ, Do RKG et al (2023) LI-RADS: looking back, looking forward. Radiology 307:e222801. https:\/\/doi.org\/10.1148\/radiol.222801","journal-title":"Radiology"},{"key":"2290_CR2","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3348\/kjr.2024.0161","volume":"25","author":"SH Choi","year":"2024","unstructured":"Choi SH, Fowler KJ, Chernyak V et al (2024) LI-RADS: current status and future directions. Korean J Radiol 25:1039\u20131046. https:\/\/doi.org\/10.3348\/kjr.2024.0161","journal-title":"Korean J Radiol"},{"key":"2290_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/JHC.S186239","volume":"6","author":"KM Elsayes","year":"2019","unstructured":"Elsayes KM, Kielar AZ, Chernyak V et al (2019) LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocell Carcinoma 6:49\u201369. https:\/\/doi.org\/10.2147\/JHC.S186239","journal-title":"J Hepatocell Carcinoma"},{"key":"2290_CR4","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.232408","volume":"313","author":"A Aslam","year":"2024","unstructured":"Aslam A, Chernyak V, Tang A et al (2024) CT\/MRI LI-RADS 2024 update: treatment response assessment. Radiology 313:e232408. https:\/\/doi.org\/10.1148\/radiol.232408","journal-title":"Radiology"},{"key":"2290_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1148\/radiol.2019182135","volume":"292","author":"EL Shropshire","year":"2019","unstructured":"Shropshire EL, Chaudhry M, Miller CM et al (2019) LI-RADS treatment response algorithm: performance and diagnostic accuracy. Radiology 292:226\u2013234. https:\/\/doi.org\/10.1148\/radiol.2019182135","journal-title":"Radiology"},{"key":"2290_CR6","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1007\/s00261-021-03122-8","volume":"46","author":"TH Kim","year":"2021","unstructured":"Kim TH, Woo S, Joo I et al (2021) LI-RADS treatment response algorithm for detecting incomplete necrosis in hepatocellular carcinoma after locoregional treatment: a systematic review and meta-analysis using individual patient data. Abdom Radiol (NY) 46:3717\u20133728. https:\/\/doi.org\/10.1007\/s00261-021-03122-8","journal-title":"Abdom Radiol (NY)"},{"key":"2290_CR7","doi-asserted-by":"publisher","first-page":"7725","DOI":"10.1007\/s00330-021-07837-6","volume":"31","author":"P Gupta","year":"2021","unstructured":"Gupta P, Bansal A, Das GC et al (2021) Diagnostic accuracy of Liver Imaging Reporting and Data System locoregional treatment response criteria: a systematic review and meta-analysis. Eur Radiol 31:7725\u20137733. https:\/\/doi.org\/10.1007\/s00330-021-07837-6","journal-title":"Eur Radiol"},{"key":"2290_CR8","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3390\/diagnostics11020237","volume":"11","author":"DW Kim","year":"2021","unstructured":"Kim DW, Choi SH, Lee JS et al (2021) Interreader reliability of Liver Imaging Reporting and Data System treatment response: a systematic review and meta-analysis. Diagnostics (Basel) 11:237. https:\/\/doi.org\/10.3390\/diagnostics11020237","journal-title":"Diagnostics (Basel)"},{"key":"2290_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.20517\/2394-5079.2022.95","volume":"9","author":"M Martin","year":"2023","unstructured":"Martin M, Aslam A, Mubarak E et al (2023) Imaging after liver-directed therapy: evidenced-based update of the LI-RADS treatment response algorithm. Hepatoma Res 9:21. https:\/\/doi.org\/10.20517\/2394-5079.2022.95","journal-title":"Hepatoma Res"},{"key":"2290_CR10","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1148\/radiol.2020192797","volume":"296","author":"S Park","year":"2020","unstructured":"Park S, Joo I, Lee DH et al (2020) Diagnostic performance of LI-RADS treatment response algorithm for hepatocellular carcinoma: adding ancillary features to MRI compared with enhancement patterns at CT and MRI. Radiology 296:554\u2013561. https:\/\/doi.org\/10.1148\/radiol.2020192797","journal-title":"Radiology"},{"key":"2290_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2214\/AJR.21.26677","volume":"218","author":"YY Kim","year":"2022","unstructured":"Kim YY, Kim MJ, Yoon JK et al (2022) Incorporation of ancillary MRI features into the LI-RADS treatment response algorithm: impact on diagnostic performance after locoregional treatment of hepatocellular carcinoma. AJR Am J Roentgenol 218:484\u2013493. https:\/\/doi.org\/10.2214\/AJR.21.26677","journal-title":"AJR Am J Roentgenol"},{"key":"2290_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00261-021-03272-9","volume":"47","author":"K Bartnik","year":"2022","unstructured":"Bartnik K, Podg\u00f3rska J, Rosiak G et al (2022) Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization. Abdom Radiol (NY) 47:115\u2013122. https:\/\/doi.org\/10.1007\/s00261-021-03272-9","journal-title":"Abdom Radiol (NY)"},{"key":"2290_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1148\/radiol.2019191581","volume":"294","author":"M Chaudhry","year":"2020","unstructured":"Chaudhry M, McGinty KA, Mervak B et al (2020) The LI-RADS version 2018 MRI treatment response algorithm: evaluation of ablated hepatocellular carcinoma. Radiology 294:320\u2013326. https:\/\/doi.org\/10.1148\/radiol.2019191581","journal-title":"Radiology"},{"key":"2290_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/HP.0000000000001601","volume":"123","author":"Y Jiao","year":"2022","unstructured":"Jiao Y, Cao F, Liu H (2022) Radiation-induced cell death and its mechanisms. Health Phys 123:376\u2013386. https:\/\/doi.org\/10.1097\/HP.0000000000001601","journal-title":"Health Phys"},{"key":"2290_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00261-017-1281-6","volume":"43","author":"A Kielar","year":"2018","unstructured":"Kielar A, Fowler KJ, Lewis S et al (2018) Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY) 43:218\u2013230. https:\/\/doi.org\/10.1007\/s00261-017-1281-6","journal-title":"Abdom Radiol (NY)"},{"key":"2290_CR16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.ijrobp.2021.10.006","volume":"112","author":"M Mendiratta-Lala","year":"2022","unstructured":"Mendiratta-Lala M, Aslam A, Maturen KE et al (2022) LI-RADS treatment response algorithm: performance and diagnostic accuracy with radiologic-pathologic explant correlation in patients with SBRT-treated hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 112:704\u2013714. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.10.006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2290_CR17","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.1007\/s00330-025-11659-1","volume":"35","author":"H Wei","year":"2025","unstructured":"Wei H, Jiang H, Yoo J et al (2025) Temporal evolution of the LI-RADS radiation treatment response assessment on multiphase CT\/MRI in patients undergoing selective internal radiation therapy for hepatocellular carcinoma. Eur Radiol 35:7349\u20137362. https:\/\/doi.org\/10.1007\/s00330-025-11659-1","journal-title":"Eur Radiol"},{"key":"2290_CR18","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M et al (2023) AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology 78:1922\u20131965. https:\/\/doi.org\/10.1097\/HEP.0000000000000466","journal-title":"Hepatology"},{"key":"2290_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","volume":"68","author":"JA Marrero","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB et al (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68:723\u2013750. https:\/\/doi.org\/10.1002\/hep.29913","journal-title":"Hepatology"},{"key":"2290_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13244-019-0801-z","volume":"10","author":"N Voizard","year":"2019","unstructured":"Voizard N, Cerny M, Assad A et al (2019) Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review. Insights Imaging 10:121. https:\/\/doi.org\/10.1186\/s13244-019-0801-z","journal-title":"Insights Imaging"},{"key":"2290_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13244-020-00884-5","volume":"11","author":"M Maas","year":"2020","unstructured":"Maas M, Beets-Tan R, Gaubert JY et al (2020) Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice. Insights Imaging 11:83. https:\/\/doi.org\/10.1186\/s13244-020-00884-5","journal-title":"Insights Imaging"},{"key":"2290_CR22","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3390\/diagnostics12071655","volume":"12","author":"F De Muzio","year":"2022","unstructured":"De Muzio F, Grassi F, Dell\u2019Aversana F et al (2022) A narrative review on LI-RADS algorithm in liver tumors: prospects and pitfalls. Diagnostics (Basel) 12:1655. https:\/\/doi.org\/10.3390\/diagnostics12071655","journal-title":"Diagnostics (Basel)"},{"key":"2290_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00261-017-1250-0","volume":"43","author":"SR Wilson","year":"2018","unstructured":"Wilson SR, Lyshchik A, Piscaglia F et al (2018) CEUS LI-RADS: algorithm, implementation, and key differences from CT\/MRI. Abdom Radiol (NY) 43:127\u2013142. https:\/\/doi.org\/10.1007\/s00261-017-1250-0","journal-title":"Abdom Radiol (NY)"},{"key":"2290_CR24","doi-asserted-by":"publisher","unstructured":"Faggian G, Faggian R, Salzano M et al (2026) Liver Imaging Reporting and Data System: current status and future perspectives in the diagnosis of hepatocellular carcinoma. Ital J Med. https:\/\/doi.org\/10.4081\/itjm.2026.2413","DOI":"10.4081\/itjm.2026.2413"},{"key":"2290_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52\u201360. https:\/\/doi.org\/10.1055\/s-0030-1247132","journal-title":"Semin Liver Dis"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02290-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-026-02290-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-026-02290-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:09:11Z","timestamp":1777302551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13244-026-02290-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2290"],"URL":"https:\/\/doi.org\/10.1186\/s13244-026-02290-9","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This is a narrative critical review based on published literature. The manuscript additionally includes fully anonymized illustrative clinical imaging presented for educational purposes only and does not involve prospective data collection, intervention, or identifiable human participant information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. All illustrative clinical images included in the manuscript are fully anonymized and contain no identifiable personal information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no financial or non-financial competing interests in relation to the work described.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}